Literature DB >> 8549863

Tumor necrosis factor-alpha and interferon-gamma inhibit insulin secretion and cause DNA damage in unweaned-rat islets. Extent of nitric oxide involvement.

A Dunger1, J M Cunningham, C A Delaney, J E Lowe, M H Green, A J Bone, I C Green.   

Abstract

Nitric oxide has been implicated as one possible mediator of interleukin-1 beta (IL-1)-induced inhibition of insulin secretion and islet cell damage. The aim of this study was to define the effects of tumor necrosis factor-alpha (TNF) and interferon-gamma (IFN) on nitric oxide production, insulin secretion, and DNA damage in islets from unweaned rats. Treatment of islets with 0.5-500 U/ml of either TNF or IFN on their own inhibited glucose-stimulated insulin secretion in a dose-dependent manner (minimum effective dose 5 U/ml). In combination, the cytokines exerted a pronounced synergistic inhibitory effect on secretion and were equipotent at causing a significant and concentration-dependent increase in culture medium nitrite levels, islet cyclic GMP formation, and DNA damage. Used alone or in combination, TNF and IFN significantly enhanced the activity of inducible nitric oxide synthase as determined by measuring the conversion of 14C-labeled arginine to 14C-labeled citrulline and nitric oxide. Use of arginine-free medium, without or with NG-monomethyl-L-arginine, resulted in inhibition of nitrite formation by 5-1,000 U/ml IFN+TNF and partial restoration of the insulin secretory response to glucose. Treatment of rat islets with increasing doses of TNF+IFN (5, 50, and 500 U/ml) resulted in a progressive increase in DNA damage, as shown by the comet assay, which detects DNA strand breaks in individual islet cells. The DNA damage caused by an intermediate concentration (50 U/ml) of TNF+IFN was comparable to that generated by IL-1 when used at 20 U/ml. We conclude that TNF and IFN induce nitric oxide formation, which partially inhibits glucose-induced insulin secretion and causes significant DNA strand breakage, but that as cytokine concentrations increase, non-nitric-oxide-mediated events predominate.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8549863     DOI: 10.2337/diab.45.2.183

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  11 in total

Review 1.  Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic Strategies.

Authors:  Prasenjit Manna; Sushil K Jain
Journal:  Metab Syndr Relat Disord       Date:  2015-12       Impact factor: 1.894

2.  A rapid qualitative method to assess in vitro immunobarrier competence of pancreatic islets containing alginate/polyaminoacidic microcapsules.

Authors:  R Calafiore; G Basta; P Sarchielli; G Luca; C Tortoioli; P Brunetti
Journal:  Acta Diabetol       Date:  1996-07       Impact factor: 4.280

3.  Effect of multiple cytokines plus bacterial endotoxin on glucose and nitric oxide production by cultured hepatocytes.

Authors:  E D Ceppi; F S Smith; M A Titheradge
Journal:  Biochem J       Date:  1996-07-15       Impact factor: 3.857

Review 4.  The central role of calcium in the effects of cytokines on beta-cell function: implications for type 1 and type 2 diabetes.

Authors:  James W Ramadan; Stephen R Steiner; Christina M O'Neill; Craig S Nunemaker
Journal:  Cell Calcium       Date:  2011-09-23       Impact factor: 6.817

5.  Branched-chain amino acid-enriched nutrients stimulate antioxidant DNA repair in a rat model of liver injury induced by carbon tetrachloride.

Authors:  Kengo Ichikawa; Takehiro Okabayashi; Yasuo Shima; Tatsuo Iiyama; Yuka Takezaki; Masaya Munekage; Tsutomu Namikawa; Takeki Sugimoto; Michiya Kobayashi; Toshiki Mimura; Kazuhiro Hanazaki
Journal:  Mol Biol Rep       Date:  2012-10-09       Impact factor: 2.316

6.  Is There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus?

Authors:  Undurti N Das
Journal:  Front Endocrinol (Lausanne)       Date:  2017-08-02       Impact factor: 5.555

7.  IFN-gamma action on pancreatic beta cells causes class I MHC upregulation but not diabetes.

Authors:  H E Thomas; J L Parker; R D Schreiber; T W Kay
Journal:  J Clin Invest       Date:  1998-09-15       Impact factor: 14.808

8.  Evidence that low-grade systemic inflammation can induce islet dysfunction as measured by impaired calcium handling.

Authors:  Stacey B Dula; Mladen Jecmenica; Runpei Wu; Pooya Jahanshahi; Gretchen M Verrilli; Jeffrey D Carter; Kenneth L Brayman; Craig S Nunemaker
Journal:  Cell Calcium       Date:  2010-08-25       Impact factor: 6.817

9.  Apoptosis in autoimmune diabetes: the fate of beta-cells in the cleft between life and death.

Authors:  Charles Sia; Arno Hänninen
Journal:  Rev Diabet Stud       Date:  2006-05-10

10.  Protective effect of Jasonia montana against ethinylestradiol-induced cholestasis in rats.

Authors:  Mohammed A Hussein; Soad M Abdel-Gawad
Journal:  Saudi Pharm J       Date:  2009-12-23       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.